Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

New series of 5-ht1F agonists disclosed by Lilly

Dec. 23, 1998

Cambridge NeuroScience and Bayer to collaborate on GGF2 development

Dec. 23, 1998

New market launch for novel anticonvulsant: Topamax available in Germany

Dec. 22, 1998

SmithKline Beecham patents combined 5-HT1A/5-HT1B/5-HT1D receptor antagonists

Dec. 22, 1998

Expanded indications, new formulation of Lamictal now available in U.S.

Dec. 21, 1998

First evidence that citicoline favorably affects human brain lipid metabolism

Dec. 21, 1998

EP1 receptor antagonists described by Ono for pain, fever and diuresis

Dec. 21, 1998

Allelix treatment for dementia enters phase I trials

Dec. 21, 1998

FDA approves Treatment IND for Orphan Medical's Xyrem oral solution

Dec. 21, 1998

U.K. launch for novel antipsychotic agent: zotepine

Dec. 18, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 12, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...